ePrep and Agilent announce new distribution partnership for the ePrep® ONE chromatography sample preparation workstation

ePrep is delighted to announce a new partnership with Agilent – a global leader in technology platforms for analytical laboratories – for the distribution of the ePrep® ONE workstation in selected regions. The ePrep ONE is a fully automated solution for end-to-end chromatography sample preparation, which Agilent will be supplying alongside its extensive portfolio of laboratory instruments. The collaboration will provide customers with new solutions for automated workflows, especially for mass spectrometry-focussed analyses.

The ePrep ONE is a unique chromatography sample preparation station that uses analytical syringes, rather than pipettes, to ensure unparalleled reliability and accuracy when preparing samples for analysis. This flexible system can be configured with a wide range of tools and accessories to meet the specific requirements of a range of sample types, batch sizes and workflows, making it particularly well suited to applied markets. The partnership with Agilent will build on the synergy between the companies and broaden the reach for the ePrep ONE in both new and existing markets, where it is already playing an important role in advancing research and testing in pharmaceutical, and environmental and food applications.

Colin Jump, CEO of ePrep, commented: “This is an exciting partnership for ePrep, and an opportunity for us to take the ePrep ONE into analytical laboratories around the world. We are passionate about empowering organisations to achieve greater efficiency, productivity and competitiveness by streamlining their sample preparation workflows, and this development will help us to achieve this. We believe the ePrep ONE complements Agilent’s technology portfolio brilliantly, and we are looking forward to seeing how this collaboration develops.”  

Lars Hartvig Kristiansen, General Manager, Automation Solutions Business at Agilent added: “The ePrep ONE is an excellent addition to our automation portfolio, offering labs a further opportunity to streamline their chromatography workflows. This partnership with ePrep allows us to support our customers in maximising productivity while delivering accurate and reliable research and testing.”

For further information on ePrep’s products and services, visit www.eprep.com.au and for company updates and new products follow their LinkedIn https://www.linkedin.com/company/eprep-sample-preparation/ 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ePrep. (2024, June 05). ePrep and Agilent announce new distribution partnership for the ePrep® ONE chromatography sample preparation workstation. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20240605/ePrep-and-Agilent-announce-new-distribution-partnership-for-the-ePrepc2ae-ONE-chromatography-sample-preparation-workstation.aspx.

  • MLA

    ePrep. "ePrep and Agilent announce new distribution partnership for the ePrep® ONE chromatography sample preparation workstation". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20240605/ePrep-and-Agilent-announce-new-distribution-partnership-for-the-ePrepc2ae-ONE-chromatography-sample-preparation-workstation.aspx>.

  • Chicago

    ePrep. "ePrep and Agilent announce new distribution partnership for the ePrep® ONE chromatography sample preparation workstation". News-Medical. https://www.news-medical.net/news/20240605/ePrep-and-Agilent-announce-new-distribution-partnership-for-the-ePrepc2ae-ONE-chromatography-sample-preparation-workstation.aspx. (accessed November 21, 2024).

  • Harvard

    ePrep. 2024. ePrep and Agilent announce new distribution partnership for the ePrep® ONE chromatography sample preparation workstation. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20240605/ePrep-and-Agilent-announce-new-distribution-partnership-for-the-ePrepc2ae-ONE-chromatography-sample-preparation-workstation.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.